SCHEMBL3392038

SCHEMBL3392038

Oc1ccc(NCCc2ccccc2)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 3/20 0.70
▸ TRPV1 Q8NER1 1/20 0.51
▸ OPRK1 P41145 1/20 0.51
▸ MEN1 O00255 3/20 0.50
▸ GAA P10253 3/20 0.50
▸ MAPT P10636 3/20 0.50
▸ BLM P54132 3/20 0.50
▸ KMT2A Q03164 3/20 0.50
▸ TP53 P04637 2/20 0.50
▸ F2 P00734 1/20 0.50
▸ KCNH2 Q12809 1/20 0.50
▸ GRIN2B Q13224 1/20 0.50
▸ ATM Q13315 1/20 0.50
▸ RAB9A P51151 2/20 0.49
▸ KDM4E B2RXH2 2/20 0.49
▸ ALDH1A1 P00352 2/20 0.49
▸ THRB P10828 2/20 0.49
▸ NPC1 O15118 1/20 0.49
▸ MTOR P42345 1/20 0.49
▸ SIRT2 Q8IXJ6 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5305854 0.92 L3MBTL1 (0.70) L3MBTL1OPRK1MAPTF2KCNH2
SCHEMBL11653014 0.89 L3MBTL1 (0.86) L3MBTL1MEN1GAAMAPTKMT2A
SCHEMBL24152726 0.89 L3MBTL1 (0.56) L3MBTL1OPRK1RAB9ANPC1MTOR
SCHEMBL21186859 0.85 L3MBTL1 (0.95) L3MBTL1MEN1GAAMAPTKMT2A
SCHEMBL88597 0.85 L3MBTL1 (0.95) L3MBTL1MEN1GAAMAPTKMT2A
SCHEMBL24375975 0.85 L3MBTL1 (0.95) L3MBTL1MEN1GAAMAPTKMT2A
Hydrochloric Acid SCHEMBL8746161 0.83 L3MBTL1 (1.00) L3MBTL1MEN1GAAMAPTKMT2A
SCHEMBL3910280 0.82 L3MBTL1 (0.73) L3MBTL1MEN1GAAMAPTKMT2A
SCHEMBL819106 0.82 L3MBTL1 (0.80) L3MBTL1MEN1GAAMAPTKMT2A
SCHEMBL24641654 0.82 L3MBTL1 (0.73) L3MBTL1GAAMAPTF2KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2393362-B1 NOVEL BENZODIAZEPINE DERIVATIVES IMMUNOGEN INC (US) 2016-08-24 — — EP disclosed
EP-2948135-A1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF PERVASIVE DEVELOPMENT DISORDERS Case Western Reserve University (US) 2015-12-02 — — EP disclosed
WO-2014117089-A1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF PERVASIVE DEVELOPMENT DISORDERS CASE WESTERN RESERVE UNIVERSITY (US) 2014-07-31 — — WO disclosed
US-20100135855-A1 METHOD FOR DEPOSITING SUBSTANCES ON A SUPPORT KONINKLIJKE PHILIPS ELECTRONICS N.V. (NL) 2010-06-03 — — US disclosed
EP-1545613-A4 DRUG CONJUGATES AND THEIR USE FOR TREATING CANCER, AN AUTOIMMUNE DISEASE OR AN INFECTIOUS DISEASE SEATTLE GENETICS INC (US) 2008-10-15 — — EP disclosed
WO-2007017652-A2 ARYLAKYLAMINES FOR THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2007-02-15 — — WO disclosed
EP-1545613-A2 DRUG CONJUGATES AND THEIR USE FOR TREATING CANCER, AN AUTOIMMUNE DISEASE OR AN INFECTIOUS DISEASE Seattle Genetics, Inc. (US) 2005-06-29 — — EP disclosed
WO-2004010957-A2 DRUG CONJUGATES AND THEIR USE FOR TREATING CANCER, AN AUTOIMMUNE DISEASE OR AN INFECTIOUS DISEASE SEATTLE GENETICS, INC. (US) 2004-02-05 — — WO disclosed
EP-1115579-A1 MONOPHASE SOLID SOLUTIONS COMPRISING A PLURALITY OF COLOUR FORMER COMPOUNDS AND PROCESS FOR THEIR PREPARATION Ciba SC Holding AG (CH) 2001-07-18 — — EP disclosed
EP-1107972-A1 PREPARATION PROCESS FOR MANUFACTURE AND PURIFICATION OF MIXTURES OF FLUORAN COMPOUNDS AND RECORDING MATERIAL COMPRISING SAID MIXTURES OF FLUORAN Ciba SC Holding AG (CH) 2001-06-20 — — EP disclosed
EP-0831081-B1 Production of aminophenols CIBA SC HOLDING AG (CH) 2000-11-02 — — EP disclosed
WO-2000026037-A1 HEAT SENSITIVE RECORDING MATERIAL CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2000-05-11 — — WO disclosed
WO-2000012513-A1 NOVEL PREPARATION PROCESS FOR MANUFACTURE AND PURIFICATION OF MIXTURES OF FLUORAN COMPOUNDS AND RECORDING MATERIAL COMPRISING SAID MIXTURES OF FLUORAN COMPOUNDS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2000-03-09 — — WO disclosed
WO-2000012318-A1 MONOPHASE SOLID SOLUTIONS COMPRISING A PLURALITY OF COLOUR FORMER COMPOUNDS AND PROCESS FOR THEIR PREPARATION CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2000-03-09 — — WO disclosed
US-5908961-A UNDER AQUEOUS ACIDIC CONDITIONS; CONTINUOUS MONITORING OFPH CIBA SPECIALTY CHEMICALS CORPORATION (US) 1999-06-01 — — US disclosed
EP-0831081-A1 Production of aminophenols Ciba SC Holding AG (CH) 1998-03-25 — — EP disclosed
Send feedback